Update Membership Claim dcbtnnext dcbtnPrevious dcbtnnext_h dcbtnPrevious_h L_ pmarker dcwatermark

Professional Statement

  • I am a Columbia/Cornell trained, board certified psychiatrist with broad training in psychotherapy, psychopharmacology, academic psychiatry, research, and community based psychiatry that allows me to develop evidence-based treatment planning that fits your specific needs. I work with patients to understand their difficulties and treat to get practical outcomes, such as improving school or work performance, relationships, or self-esteem. I look forward to listening to you and learning more about you so that we can work together in helping you reach your goals.
  • I work out-of-network with insurance companies, and most of my patients that use their insurance benefits are successfully reimbursed 50-100% of my fees, depending on their insurance plan.
  • More about me:
  • I treat children, adolescents, and adults. I am an assistant professor of clinical psychiatry at Columbia University, College of Physicians & Surgeons. I have presented at conferences, published scientific papers, and supervise trainees at Columbia University and NYU.
  • In my private practice, I provide diagnostic consultations, psychopharmacologic management, and psychotherapy. If you are already in psychotherapy, I will work with your therapist to achieve the best result. Evening appointments are available. To learn more, please contact me directly or visit my website at www.tejalkaurmd.com

Education & Training

  • Medical School - University of California, San Diego
  • University of California, San Diego Medical Center (Residency)
  • NewYork-Presbyterian Hospital / Columbia University Medical Center, Fellowship in Child and Adolescent Psychiatry

Board Certifications

  • American Board of Psychiatry and Neurology
  • Child & Adolescent Psychiatry (Psychiatry and Neurology)

Awards and Publications

  • 2011 Awardee, Barbara Ann Liskin Memorial Award, Columbia University
  • 2011 Awardee, American Psychiatric Association (APA) Sixteenth Annual Research Colloquium for Junior Investigators
  • 2011-2012 Chief Resident, New York Presbyterian University Hospital of Columbia and Cornell
  • 2005 Travel Grant Awardee, APA Annual Conference to serve on APA Committee on PSYCHSIGN: Psychiatry Interest Group Network
  • 2002 Designation as “University of Southern California Renaissance Scholar”: $10,000 award presented for excelling in diverse academic subjects representing the breadth and depth of undergraduate major and minors
  • 2002 Phi Beta Kappa
  • 2000 Alpha Epsilon Delta
  • 1998 Trustee Scholar and recipient of full tuition scholarship at University of Southern California
  • Publications
  • 2012 Rube DM & Kaur T. Attention Deficit-Hyperactivity Disorder. In: Klykylo W and Kay J, Eds. Clinical Child Psychiatry, Third Edition. London, John Wiley & Sons Ltd, 2012.
  • 2012 Heleniak C, Kaur T, Ghalib K, Rynn M. (2011) Tricyclic Antidepressants and Monoamine Oxidase Inhibitors for the Treatment of Child and Adolescent Psychiatric Disorders, in D. Rosenberg & S. Gershon (Ed.): Pharmacotherapy of Child and Adolescent Psychiatric Disorders, Third edition. Wiley Blackwell, Hoboken, NJ.
  • 2011 Kaur T, Dobroshi Z, McCarthy J, Coffey BJ: New onset of psychotic symptoms in an adolescent with pervasive developmental disorder, not otherwise specified. Journal of Child and Adolescent Psychopharmacology 2011;21(1):87-90
  • 2010 Kaur T & Cadenhead, KS. (2010) Treatment Implications of the Schizophrenia Prodrome, in N. Swerdlow (Ed.): Behavioral Neurobiology of Schizophrenia and Its Treatment. Springer Publishing Company, New York, NY.
  • 2009 Kaur T, Shafer K, Cadenhead KS. “Reliability of repeated assessment of attentional performance in individuals at risk for psychosis and in the first episode of schizophrenia,” International Congress on Schizophrenia Research, San Diego, CA, March 2009
  • 2007 Kaur T, Shafer K, Cadenhead KS. “The Relationship of Olfaction, Neurocognition and Symptom Measures in the Prodrome and First Episode of Schizophrenia,” Society of Biological Psychiatry’s 62nd Annual Scientific Convention & Program, San Diego, CA, May 2007
  • 2007 Ballon JS, Kaur T, Marks II, Cadenhead KS: Social functioning in young people at risk for schizophrenia. Psychiatry Research 2007;151(1-2):29-35
  • 2006 Kaur T, Shafer K, Marks II, Cadenhead KS. “Olfactory dysfunction in individuals at risk for schizophrenia and first episode subjects: a cross-sectional analysis,” 5th International Conference on Early Psychosis, Birmingham, UK, October 2006

Professional Memberships

  • American Psychiatric Association

Language Spoken

  • English
  • Marathi
  • Spanish